It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Bayer will partner with BioNTech to develop novel, first-in-class mRNA vaccines and therapeutics for animal health indications, the companies said today, under a collaboration whose value was not disclosed.
Bayer agreed to secure exclusive rights to BioNTech’s mRNA technology and intellectual property for development of mRNA vaccines for animal health applications…
The companies said their partnership is the first of its kind focused on developing mRNA therapeutics specifically for animal health applications.
…
Infectious disease vaccines is the focus of one of the three therapy platforms BioNTech is building through mRNA technologies; the other two are cancer immunotherapies and protein replacement. The three platforms are designed to produce pharmacologically optimized protein coding RNA for targeted in vivo delivery…
"Following discussions with the German government it has become clear that current manufacturing capacities for vaccines need to be increased, particularly for potential variants of the SARS-CoV-2 virus.
This includes the need to expand production capacity as well as related manufacturing expertise in Germany.
We at Bayer will contribute even further by making more vaccine available to help fight the pandemic.
Combat current and future swine diseases with SEQUIVITY from Merck Animal Health. A revolutionary swine vaccine platform, SEQUIVITY harnesses RNA particle technology to create customized prescription vaccines against strains of influenza A virus in swine, porcine circovirus (PCV), rotavirus and beyond. It’s supported by a sophisticated dashboard filled with comprehensive data and insights, all to help you stay on top.
mRNA Vaccines in our food...
Poisoning the water supply technically would be just as bad air sprays. Because it becomes "uncontrolled".
originally posted by: olaru12
a reply to: BlackArrow
Do you remember when they sprayed the subway tunnels just to see how effective an aerosol would be.
www.businessinsider.com...
If they can put chemicals such as chloride, sodium hypochlorite into public water consumption systems mRNA shouldn't be a problem.
Poisoning the water supply technically would be just as bad air sprays. Because it becomes "uncontrolled".
When and if they really intend to implement the purge; why do you think they want to control it?
originally posted by: v1rtu0s0
originally posted by: olaru12
a reply to: BlackArrow
Do you remember when they sprayed the subway tunnels just to see how effective an aerosol would be.
www.businessinsider.com...
If they can put chemicals such as chloride, sodium hypochlorite into public water consumption systems mRNA shouldn't be a problem.
Poisoning the water supply technically would be just as bad air sprays. Because it becomes "uncontrolled".
When and if they really intend to implement the purge; why do you think they want to control it?
It's already started. It's controlled demolition of society for the "good of mankind and planet earth."
originally posted by: MPoling
It appears they have found a way to force the vaccine to those of us who stood against the mass propaganda over the last two years.
rwmalonemd.substack.com...
Bayer will partner with BioNTech to develop novel, first-in-class mRNA vaccines and therapeutics for animal health indications, the companies said today, under a collaboration whose value was not disclosed.
Bayer agreed to secure exclusive rights to BioNTech’s mRNA technology and intellectual property for development of mRNA vaccines for animal health applications…
The companies said their partnership is the first of its kind focused on developing mRNA therapeutics specifically for animal health applications.
…
Infectious disease vaccines is the focus of one of the three therapy platforms BioNTech is building through mRNA technologies; the other two are cancer immunotherapies and protein replacement. The three platforms are designed to produce pharmacologically optimized protein coding RNA for targeted in vivo delivery…
The above quote was from 2016...this has long been planned.
Now from 2021
"Following discussions with the German government it has become clear that current manufacturing capacities for vaccines need to be increased, particularly for potential variants of the SARS-CoV-2 virus.
This includes the need to expand production capacity as well as related manufacturing expertise in Germany.
We at Bayer will contribute even further by making more vaccine available to help fight the pandemic.
And this from 2023
Combat current and future swine diseases with SEQUIVITY from Merck Animal Health. A revolutionary swine vaccine platform, SEQUIVITY harnesses RNA particle technology to create customized prescription vaccines against strains of influenza A virus in swine, porcine circovirus (PCV), rotavirus and beyond. It’s supported by a sophisticated dashboard filled with comprehensive data and insights, all to help you stay on top.
There is a lot more in the article outlinning how they have been planning to use mRNA in our food for the last 6 years. And because its animals there is not a clear clinical trials website where we can see the effects.
A common myth of vaccines that has appeared in recent months is the accusation they remain active in the body for extended periods of time—a claim which has increased vaccine hesitancy in some people.
However, vaccines are cleared from your body in mere days or weeks. It's the immune response against the SARS-CoV-2 virus that appears to last for a long time.
Messenger RNA or mRNA technology, used in COVID-19 vaccines, works by teaching our cells to recognize and protect us against infectious diseases.
One of the challenges with this new technology is that it must be kept cold to maintain stability during transport and storage. If this new project is successful, plant-based mRNA vaccines — which can be eaten — could overcome this challenge with the ability to be stored at room temperature.
The project’s goals, made possible by a $500,000 grant from the National Science Foundation, are threefold: showing that DNA containing the mRNA vaccines can be successfully delivered into the part of plant cells where it will replicate, demonstrating the plants can produce enough mRNA to rival a traditional shot, and finally, determining the right dosage.